Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAKAR HEALTHCARE vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SAKAR HEALTHCARE    ADCOCK INGRAM
EQUITY SHARE DATA
    SAKAR HEALTHCARE
Mar-23
ADCOCK INGRAM
Jun-14
SAKAR HEALTHCARE /
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs295331-   
Low Rs112238-   
Sales per share (Unadj.) Rs70.098.3-  
Earnings per share (Unadj.) Rs6.7-24.8-  
Cash flow per share (Unadj.) Rs14.6-20.5-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs91.077.2-  
Shares outstanding (eoy) m19.04168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.92.9 100.4%   
Avg P/E ratio x30.4-11.5 -264.3%  
P/CF ratio (eoy) x14.0-13.9 -100.7%  
Price / Book Value ratio x2.23.7 60.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,87348,025 8.1%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m1583,014 5.2%   
Avg. sales/employee Rs Th03,866.4-  
Avg. wages/employee Rs Th0702.1-  
Avg. net profit/employee Rs Th0-974.2-  
INCOME DATA
Net Sales Rs m1,33416,598 8.0%  
Other income Rs m47116 40.2%   
Total revenues Rs m1,38016,715 8.3%   
Gross profit Rs m333-2,876 -11.6%  
Depreciation Rs m150716 20.9%   
Interest Rs m60450 13.3%   
Profit before tax Rs m170-3,926 -4.3%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m42245 17.3%   
Profit after tax Rs m128-4,182 -3.1%  
Gross profit margin %24.9-17.3 -143.9%  
Effective tax rate %24.9-6.2 -398.7%   
Net profit margin %9.6-25.2 -38.0%  
BALANCE SHEET DATA
Current assets Rs m55912,157 4.6%   
Current liabilities Rs m5456,840 8.0%   
Net working cap to sales %1.132.0 3.3%  
Current ratio x1.01.8 57.7%  
Inventory Days Days29111 26.6%  
Debtors Days Days604124 487.5%  
Net fixed assets Rs m2,8047,086 39.6%   
Share capital Rs m19077 247.1%   
"Free" reserves Rs m1,5430-   
Net worth Rs m1,73313,028 13.3%   
Long term debt Rs m9824,578 21.5%   
Total assets Rs m3,36324,611 13.7%  
Interest coverage x3.8-7.7 -49.8%   
Debt to equity ratio x0.60.4 161.2%  
Sales to assets ratio x0.40.7 58.8%   
Return on assets %5.6-15.2 -36.7%  
Return on equity %7.4-32.1 -22.9%  
Return on capital %8.5-19.8 -42.7%  
Exports to sales %78.40-   
Imports to sales %00-   
Net fx Rs m6900-   
CASH FLOW
From Operations Rs m3331,417 23.5%  
From Investments Rs m-744-435 171.0%  
From Financial Activity Rs m4114,155 9.9%  
Net Cashflow Rs m15,137 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.56 Rs / ZAR

Compare SAKAR HEALTHCARE With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SAKAR HEALTHCARE With: ORCHID PHARMA  J.B.CHEMICALS  DECCAN HEALTH CARE  LUPIN  RPG LIFE SCIENCES  



Today's Market

Page Industries Q4 Results | ITC to Seek Demerger Approval | Top Buzzing Stocks Today Page Industries Q4 Results | ITC to Seek Demerger Approval | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended on firm footing.